Form 8-K - Current report:
SEC Accession No. 0000950129-04-009374
Filing Date
2004-11-24
Accepted
2004-11-24 16:42:18
Documents
2
Period of Report
2004-11-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ENCYSIVE PHARMACEUTICALS INC.- NOVEMBER 24, 2004 h20539e8vk.txt 8-K 4671
2 LEASE AGREEMENT h20539exv10w1.txt EX-10.1 128760
  Complete submission text file 0000950129-04-009374.txt   135365
Mailing Address
Business Address 6700 WEST LOOP SOUTH 4TH FLOOR BELLAIRE TX 77401 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20117 | Film No.: 041167688
SIC: 2834 Pharmaceutical Preparations